Tenaya Therapeutics (TNYA) Change in Acquisitions & Divestments (2022 - 2025)

Tenaya Therapeutics has reported Change in Acquisitions & Divestments for 4 years, with the latest figure at $34.8 million in Q3 2025.

• For the quarter ending Q3 2025, Change in Acquisitions & Divestments rose 68.2% year-over-year to $34.8 million; the trailing twelve-month figure through Mar 2026 stood at $34.0 million (down 53.54% YoY), and the FY2025 full-year result was $45.7 million, down 43.67% from the prior year.
• Change in Acquisitions & Divestments for Q3 2025 stood at $34.8 million, up from -$769000.0 in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $78.7 million in Q3 2022, with the low at -$769000.0 in Q2 2025.
• Average Change in Acquisitions & Divestments over 4 years is $31.9 million, with a median of $32.5 million recorded in 2024.
• Year-over-year, Change in Acquisitions & Divestments surged 630.55% in 2024 and tumbled 102.37% in 2025.
• Tracing TNYA's Change in Acquisitions & Divestments over 4 years: stood at $38.5 million in 2022, then tumbled by 97.04% to $1.1 million in 2023, then surged by 630.55% to $8.3 million in 2024, then jumped by 318.04% to $34.8 million in 2025.
• The last three Change in Acquisitions & Divestments figures came in at $34.8 million (Q3 2025), -$769000.0 (Q2 2025), and $11.7 million (Q1 2025), per Business Quant data.

Peer Comparison